US Bancorp’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding SBIO
CIS
MWM
GAM
US Bancorp's SBIO Position: Q2 2026 in Review
US Bancorp held its ALPS Medical Breakthroughs ETF (SBIO) position steady in Q2 2026 at 1,000 shares worth $64.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2679.
US Bancorp first reported a position in SBIO in Q4 2019 and has held it in 27 quarters since. The position peaked at $100K in Q2 2020. 65 funds tracked by Wall St. Rank hold SBIO as of Q2 2026.
- US Bancorp held 1,000 shares of ALPS Medical Breakthroughs ETF worth $64.7K as of Q2 2026.
- US Bancorp left its ALPS Medical Breakthroughs ETF share count unchanged in Q2 2026.
- ALPS Medical Breakthroughs ETF made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #2679 holding.
- US Bancorp first reported a position in ALPS Medical Breakthroughs ETF in Q4 2019 and has held it in 27 quarters since.
- US Bancorp's ALPS Medical Breakthroughs ETF position peaked at $100K in Q2 2020.
- 65 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2026.
Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.